Our company

An Oxford spin-out, fourteen years on.

Founded in 2012 from a ground-breaking Oxford study on multiparametric MRI for liver disease. Today, a global precision health company with sites in Oxford and Boston, 250 employees including 70+ PhDs, and partners across the world.

Company Vision

To build a better tomorrow for patients through scientific innovation. To empower patients and clinicians to better understand chronic systemic diseases, enabling early detection, diagnosis, and targeted treatment.

Four interlinked business units.

Perspectum operates through four units that share an R&D platform and a single quantitative-imaging philosophy.

Pharma Solutions

Imaging partner for trial sponsors. 46 customers, 11 big-pharma names, 87 clinical trials, $100M backlog, ~80% gross margins.

Clinical Diagnostics

US service-line and direct-pay business. 147M lives covered, CPT codes awarded, Cat I CPT transition in flight.

Oxford CDC

NHS-approved Community Diagnostic Centre. 60,000 patients/year, growing to 100,000+ by 2027. InHealth national partnership.

Medical Solutions

The R&D engine. ~8 months concept-to-FDA-clearance on average. The product flywheel.

Origin

From a single Oxford study, in 2012.

The foundation was laid by a ground-breaking study at the University of Oxford demonstrating the potential of multiparametric MRI to assess patients with liver disease.

The start-up founded in partnership with the University of Oxford has since grown into Perspectum, a major player in digital medical technology and diagnostics. We strive to deliver technologies that help clinicians provide better care for patients with liver and bile diseases, long COVID, diabetes, and cancer, through continued collaboration with world-renowned researchers and clinicians.

"Our team envisions a future where doctors and patients can shape personalized medical care."

Locations

Oxford, UK

Head office. Gemini One, 5520 John Smith Drive, Oxford OX4 2LL. Co-located with the Oxford Community Diagnostic Centre at the Oxford University Hospitals NHS Foundation Trust.

Boston, USA

245 Main Street, Kendall Square, Cambridge, MA 02142. North American operations, pharma services, clinical partnerships, and the FDA-cleared product business.

Lisbon, Europe

EU authorised representative. Avenida Antonio Augusto de Aguiar 19, 1050-012 Lisbon, Portugal.

Singapore

Rest-of-world office. Centennial Tower, 3 Temasek Avenue, Singapore 039190.

Senior management.

A leadership team that brings together world-leading physicians, scientists, and operators, united behind one vision, building a better tomorrow for patients.

RN
Dr Rexford Newbould
Interim CEO
MB
Professor Sir Michael Brady
Co-founder
MRI
Dr Matthew Robson
Chief Technical Officer
MM
Marija Mavar
President, Pharma Solutions
MA
Mehru Asad
VP People Success
AC
Amanda Chin
SVP Investor Relations
AB
Andrea Borghetto
SVP Commercial Operations

Board of Directors.

Governance, oversight, and strategic guidance as the company continues to grow.

Dr Michael Rosenblatt (Executive Director)
Sam Brasch
Dato’ Lee Yeow Chor, DSAP
Carmine Circelli
James Davis
Matt Downs
Robert Lowenthal
Chun Tan
Ellen Zane

Standards and compliance.

The standards and certifications behind the platform. All current as of Q2 2026.

Quality system

ISO 13485 certified

Medical device quality management. Active certification covering design, development, production, and post-market surveillance. Audit history available on request.

Regulatory

FDA 510(k) cleared

Multiple FDA-cleared products in the clinical portfolio. UKCA, CE Mark, and PMDA pathways active in parallel. Health Canada under submission.

Data & privacy

HIPAA, GDPR, SOC 2

HIPAA-compliant US operations; GDPR-compliant EU/UK operations; SOC 2 Type II certification. Cyber posture reviewed quarterly by the audit committee.

Intellectual property

Active patent estate

cT1, PDFF-derived methods, MRCP+ post-processing, and the PAIR family. Patent estate managed by an in-house IP team across five jurisdictions.

Board governance

Independent oversight

Independent chair, audit committee, remuneration committee, and clinical advisory board.

Sustainability & trust

Armed Forces Covenant signatory

Public commitment to the UK Armed Forces Covenant. Modern Slavery Act statement current. ESG framework reviewed by the board, refreshed annually.

Reach
1,200+Sites
Worldwide using Perspectum services across clinical and research settings.
100+Partners
Research partners across academic, NHS, government, and pharma collaborations.
40k+Datasets
Trial datasets processed through our quantitative imaging core lab to date.

News & events.

Recent milestones, leadership, partnerships, and where to find the Perspectum team.

  • Company news and announcements
  • Upcoming conferences and events
View news & events →

Help us build a better tomorrow.

Roles across Oxford and Boston, engineering, data science, clinical, commercial, operations, and beyond.

See open roles → Contact the team
Concept · Company · Send feedback